The Food and Drug Administration (FDA) has reached an agreement with Abbott Nutrition on a plan to restart production at the Michigan baby formula plant to combat the shortage crisis.
The Food and Drug Administration has reached an agreement with Abbott Nutrition on a plan to restart production at the Michigan baby formula plant to combat the shortage crisis.
This past February, Abbott Nutrition instituted a recall after four illnesses were reported in babies who had consumed powdered formula from the Sturgis, Michigan plant, helping to fuel the ongoing baby formula shortage that has created considerable concern among parents. “After a six-week inspection, FDA investigators published a list of problems in March, including lax safety and sanitary standards and a history of bacterial contamination in several parts of the plant,” noted the“Chicago-based Abbott has emphasized that its products have not been directly linked to the bacterial infections in children,” it added. “Samples of the bacteria found at its plant did not match the strains collected from the babies by federal investigators.
Since Abbott is just one of four companies that control 90 percent of the baby formula market, coupled with the ongoing supply-chain crisis, a shortage ensued., Abbott Nutrition said that the FDA agreement produced the “steps necessary to resume production and maintain the facility,” though it will still need court approval. Once given the official go-ahead by the FDA, Abbott said it could resume production of infant formula in two weeks.
“This is something he is focusing on very acutely and again I said 24/7 we’ve been working on this since we have learned about this back in February,”
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA, Abbott agree on plan to resume production of infant formula at Michigan plantBREAKING: FDA and Abbott Nutrition agree on plan to resume operations at its infant formula facility in Sturgis, Michigan, the company announces.
Les mer »
FDA, Abbott agree on plan to resume production of infant formula at Michigan plantWASHINGTON — The Food and Drug Administration and Abbott Nutrition have agreed on a plan to resume operations at its infant formula facility in Sturgis, Michigan, the company announced on Monday.
Les mer »
FDA and Abbott Nutrition Announce Plans to Safely Reopen Bacteria-Riddled Baby Formula PlantAfter operations resume, it could still be six to eight weeks until baby formula is back on the shelves, Abbott representatives confirmed.
Les mer »
Baby formula maker Abbott says agreement reached with FDA to reopen Sturgis, Michigan facilityAfter production resumes, Abbott has said it will take at least eight weeks to begin shipping new product to stores.
Les mer »
Abbott reaches deal with FDA to reopen Michigan baby formula plantThe White House said it is working with all major formula producers to boost production, including reaching out to their suppliers to encourage them to prioritize production and delivery of formula ingredients.
Les mer »
Baby formula maker Abbott says agreement reached with FDA to reopen Sturgis, Michigan facilityBaby formula maker Abbott Labs said it will take at least 8 weeks to begin shipping new product after production resumes at its Sturgis, MI plant.
Les mer »